Evidence map›Paper›PMID 33956176›Full record

ArticleMammalian genome : official journal of the International Mammalian Genome Society2021

The miR-302s/367 Cluster Inhibits the Proliferation and Apoptosis in Sheep Fetal Fibroblasts via the Cell Cycle and PI3K-Akt Pathways.

Xian Wu, Ruiying Tong, Xiuli Chen, Xinying Jiang, Xiaoying He, Libing Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Twist1 Promoter Methylation Regulates the Proliferation and Apoptosis of Acute Myeloid Leukemia Cells via PI3K/AKT Pathway.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xian WuSchool of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Ruiying TongSchool of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Xiuli ChenSchool of Biological Science and Technology, Baotou Teachers' College, Baotou, Inner Mongolia, China.
Xinying JiangSchool of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Xiaoying HeSchool of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Libing MaSchool of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China. mlb-xn2004@163.com.ORCID 0000-0002-2607-3692
Inner Mongolia University of Science and Technology · CNBaotou Teachers College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The miR-302s/367 family has the ability to induce mouse and human somatic cell reprogramming into induced pluripotent stem cells (iPSCs), inhibit the proliferation of several types of cancer cells, and even cause cancer cell apoptosis. However, the functions of the miR-302s/367 family in other mammals have not been explored. In the present study, the effects of miR-302s/367 on reprogramming, proliferation, and apoptosis in sheep fetal fibroblasts (SFFs) were evaluated by the delivery of a plasmid vector containing synthetic precursor miRNAs into cells, followed by the induction of mature miR-302s/367 expression. The results showed that miR-302s/367 could not reprogram SFFs into iPSCs; however, they could inhibit both the proliferation and apoptosis of SFFs by targeting CDK2, E2F1, E2F2, and PTEN in the cell cycle and PI3K-Akt pathways. Based on our findings, a novel mechanism was proposed in which the miR-302s/367 family functions in both the proliferation and apoptosis of somatic cells in mammals, suggesting that caution is needed when using miR-302s/367 as therapeutic agent.

Indexed as

AnimalsApoptosisCell CycleCell ProliferationFetusFibroblastsHumansMiceMicroRNAsOncogene Protein v-aktPhosphatidylinositol 3-KinasesSheepSignal TransductionMicroRNAsMIRN302 microRNA, mouseMIRN367 microRNA, mouseOncogene Protein v-aktPhosphatidylinositol 3-Kinases

Identifiers

PMID33956176
OpenAlexW3159083966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.